tirzepatide itchy at injection site TrimRX Injection Site Reactions with Tirzepatide:

When will it launch

Brunner went on to describe compoundings growing prevalence and controversy in light of the emergence of GLP-1 drugs, originally indicated for weight loss and diabetes and sold under brands such as Ozempic, Wegovy and Mounjaro

A large observational study using US Medicare data expands on prior evidence regarding the association between the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and an increased risk of developing nonarteritic anterior ischemic optic neuropathy (NAION) in older patients with type 2 diabetes

The Effect of a Future-Self Avatar mHealth Intervention on Physical Activity and Food Purchases: The FutureMe Randomized Controlled Trial

Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial